Immunosuppressive Agents: all 5,940 studies that test it

Page 32 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.

• The Effect of Local Analgesia on Postoperative Gluteal Pain in Patients Undergoing Sacrospinous Ligament FixationWithdrawnNCT03995641Phase 4
• Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid TumorsTerminatedNCT03992326Phase 1
• Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic LeukemiaCompletedNCT03991884Phase 1
• Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of LifeStatus unknownNCT03987152Phase 3
• Optimizing PTCy Dose and TimingActive, not recruitingNCT03983850Phase 1/2
• BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD)Status unknownNCT03982771Phase 2
• New Therapies and Biomarkers for Chagas InfectionCompletedNCT03981523Phase 2
• Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.WithdrawnNCT03978494Phase 1
• NPC-12G Gel 0.2% Sirolimus PK Bridging StudyCompletedNCT03972462Phase 1
• Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal TransplantationCompletedNCT03968588Phase 4
• Rituximab and Belimumab Combination Therapy in PR3 VasculitisStatus unknownNCT03967925Phase 2
• Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid TumorsActive, not recruitingNCT03967223Phase 2
• Leflunomide in Treating Patients With High-Risk Smoldering Multiple MyelomaWithdrawnNCT03952832Phase 2
• Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid TumorsActive, not recruitingNCT03950609Phase 2
• Fingolimod in Treating Patients With Chemotherapy-Induced NeuropathyCompletedNCT03943498Early Phase 1
• The Efficacy and Safety of Sirolimus for Plastic BronchitisStatus unknownNCT03942926Phase 2
• Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated VasculitisStatus unknownNCT03942887Phase 3
• Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast CancerCompletedNCT03941743Phase 1
• Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 DiabetesActive, not recruitingNCT03936829Not applicable
• Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 DiabetesActive, not recruitingNCT03929601Phase 2
• Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant TransplantActive, not recruitingNCT03924401Phase 2
• Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance TherapyStatus unknownNCT03920813Phase 4
• Tacrolimus Treatment for Refractory Autoimmune CytopeniaStatus unknownNCT03918265Phase 4
• A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaActive, not recruitingNCT03914625Phase 3
• Intralesional Steroid Injection Versus Voice Therapy in Management of Vocal NodulesCompletedNCT03914092Phase 4
• Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant CyclophosphamideActive, not recruitingNCT03910452Early Phase 1
• Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of InfluenzaActive, not recruitingNCT03901001Phase 3
• A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's SyndromeActive, not recruitingNCT03899337Phase 2
• Pharmacokinetic Drug-Drug Interaction StudyCompletedNCT03892213Phase 1
• Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast CancerCompletedNCT03888677Phase 3
• Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
• Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent PatientsCompletedNCT03877809Phase 2
• Umbilical Cord Blood Transfusion in Progeria SyndromeCompletedNCT03871972Phase 1/2
• Abatacept in Patients With Birdshot HLA A29 UveitisCompletedNCT03871361Phase 2
• Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNHStatus unknownNCT03866681Phase 4
• Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren SyndromeCompletedNCT03865888Phase 3
• Tacrolimus Monotherapy for Idiopathic Membranous NephropathyStatus unknownNCT03864250Not applicable
• A Study to Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study ParticipantsCompletedNCT03859219Phase 1
• 'ADVANCE' (A Pilot Trial)Active, not recruitingNCT03858322Phase 1
• To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple SclerosisCompletedNCT03856619Phase 4
• Study Evaluating the Safety and Efficacy of C-CHOP in Untreated Subjects With Angioimmunoblastic T Cell LymphomaStatus unknownNCT03853044Phase 2
• A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative ColitisTerminatedNCT03844932Phase 2
• Targeting the Tumor Microenvironment in R/M SCCHNStatus unknownNCT03844763Phase 1/2
• Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic SclerosisActive, not recruitingNCT03844061Phase 2
• Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney TransplantsActive, not recruitingNCT03841097Phase 4
• DLCL002 Protocol for Patients With High Risk Aggressive B-cell LymphomaStatus unknownNCT03837873Phase 2
• Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis AlbaStatus unknownNCT03834935Phase 2/3
• Autologous Transplant To End NMO Spectrum DisorderWithdrawnNCT03829566Phase 2/3
• Veloxis de Novo Kidney Transplant ECSWDStatus unknownNCT03828682Phase 4
• Envarsus XL Immunosuppression Following Liver TransplantationCompletedNCT03828058Phase 2
• A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)Active, not recruitingNCT03821610Phase 2
• Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitisCompletedNCT03815448Not applicable
• The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian CancerStatus unknownNCT03814447Early Phase 1
• Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell StratificationStatus unknownNCT03813771Phase 4
• Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and DesensitizationWithdrawnNCT03805178Phase 2
• MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian CancerStatus unknownNCT03799913Early Phase 1
• Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft OutcomeCompletedNCT03794492Phase 4
• BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's LymphomaCompletedNCT03794167Phase 2
• Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney TransplantationStatus unknownNCT03789006Phase 4
• Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers SyndromeStatus unknownNCT03781050Phase 4
• The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With MegestrolStatus unknownNCT03777930Phase 4
• Methotrexate and Prednisolone Study in Erythema Nodosum LeprosumActive, not recruitingNCT03775460Not applicable
• Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung DiseaseStatus unknownNCT03770663Phase 3
• A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy AdultsCompletedNCT03768609Phase 1
• Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous MalformationStatus unknownNCT03767660Phase 4
• Bioequivalence Study of NPC-12 (Sirolimus) Granules and TabletsCompletedNCT03765944Phase 1
• Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release TacrolimusCompletedNCT03760263Phase 4
• Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17Active, not recruitingNCT03755804Phase 2
• The Vienna Prograf and Endothelial Progenitor Cell Extension StudyCompletedNCT03751332Phase 4
• Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast CancerStatus unknownNCT03749850Phase 1
• Adult Healthy Volunteers Study to Evaluate ALPN-101 SafetyCompletedNCT03748836Phase 1
• Synergetic B-cell Immunomodulation in SLE - 2nd Study.CompletedNCT03747159Phase 3
• Benznidazole Absorption, Metabolism and Excretion StudyCompletedNCT03739541Phase 1
• A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)CompletedNCT03737708Phase 4
• GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid TumorsCompletedNCT03733587Phase 1
• BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCTStatus unknownNCT03733327Phase 2/3
• Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) HaploinsufficiencyWithdrawnNCT03733067Phase 1/2
• Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell LymphomaWithdrawnNCT03719560Phase 2
• Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple MyelomaStatus unknownNCT03716856Phase 1
• Leflunomide Treatment for IgG4-RDStatus unknownNCT03715699Not applicable
• Tacrolimus for Malar EdemaStatus unknownNCT03715387Phase 2/3
• CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple MyelomaSuspendedNCT03710421Phase 1
• Investigation of Flare and Remission in Subjects With Atopic DermatitisWithdrawnNCT03710044Phase 4
• Leflunomide in Previously Treated Metastatic Triple Negative CancersCompletedNCT03709446Phase 1/2
• Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple MyelomaCompletedNCT03700450Phase 2
• The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in ChildrenStatus unknownNCT03692416Phase 3
• PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisStatus unknownNCT03689465Phase 4
• Study of Sirolimus in CTD-TP in ChinaStatus unknownNCT03688191Phase 4
• Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive RegimenActive, not recruitingNCT03672110Phase 3
• EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis(PALABA Study)CompletedNCT03669367Phase 4
• Optimization of Golimumab Treatment in Ulcerative ColitisStatus unknownNCT03669029Phase 4
• The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye SyndromeCompletedNCT03666884Phase 4
• Study of Sirolimus in Patients With Advanced Pancreatic CancerStatus unknownNCT03662412Phase 1/2
• A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)CompletedNCT03660059Phase 3
• IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver CancerActive, not recruitingNCT03655002Phase 1
• Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AMLStatus unknownNCT03654703Phase 2
• Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent ThalassemiaCompletedNCT03651102Phase 2/3
• Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant RecipientsCompletedNCT03644485Phase 4
• A Study of Deflazacort (Emflaza®) in Participants With Duchenne Muscular Dystrophy (DMD)WithdrawnNCT03642145Phase 3
• Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease PatientsTerminatedNCT03640026Phase 4

← Immunosuppressive Agents overview